SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 56.20 |
Enterprise Value ($M) | 25.66 |
Book Value ($M) | 68.87 |
Book Value / Share | 2.79 |
Price / Book | 0.82 |
NCAV ($M) | 60.48 |
NCAV / Share | 2.45 |
Price / NCAV | 0.93 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.88 |
Return on Assets (ROA) | -0.44 |
Return on Equity (ROE) | -0.52 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.54 |
Current Ratio | 4.89 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 77.31 |
Assets | 85.70 |
Liabilities | 16.83 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Desai Neil | 8.50 | -19.64 | |
13G | EcoR1 Capital, LLC | 7.50 | ||
13G | BML Investment Partners, L.P. | 5.60 | -34.41 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
11,030 | 54,791 | 20.13 | |
18,843 | 195,952 | 9.62 | |
20,615 | 60,935 | 33.83 | |
50,558 | 111,257 | 45.44 | |
19,018 | 83,390 | 22.81 | |
(click for more detail) |
Similar Companies | |
---|---|
ABEO – Abeona Therapeutics Inc. | ABVC – ABVC BioPharma, Inc. |
Financial data and stock pages provided by
Fintel.io